In this section, you will find a range of GPA resources including our annual reports and publications.
WHAT IS PSORIASIS?
Psoriasis is a life-long skin condition, for which there is no cure.
It occurs when skin cells reproduce at a faster rate than normal. The skin cells build up and cause raised patches to form. These patches can be red (on Caucasian skin) or appear more as purple patches with grey scales (on darker skin tones). They can also be flaky, itchy and scaly.
Psoriasis can flare up anywhere on the body and can be severe or mild. Some people can go for long periods without their psoriasis flaring up, but other people may experience regular flare-ups. Its visibility and the misconception that it is contagious, means it is often stigmatising. This is an additional burden to the physical discomfort it may cause. Psoriasis affects people physically and psychologically, and has also been associated with other conditions.
One of the aims of the GPA is to understand the number of people around the world who are affected by psoriasis, and what care and treatment is available to them wherever they may live. We know that psoriasis can be managed well if people receive appropriate and timely advice and treatment.
GPA HEALTHCARE SURVEY
PD Dr Julia-Tatjana Maul was awarded an International Psoriasis Council (IPC) fellowship for the year 2020 which allowed her to continue her work on epidemiological data collection that she began in Latin America in 2018, on behalf of the GPA.
ANNOUNCING THE LAUNCH OF OUR NEW WEBSITE
The Global Psoriasis Atlas (GPA) team are excited to announce the launch of our newly designed website. We wanted to create a site that is faster, easier to navigate and more user-friendly.
COMMON MISCONCEPTIONS ABOUT PSORIASIS
Psoriasis is a long-lasting, immune-mediated skin disease. Because of its visibility and misconception that it is contagious, it is often stigmatising. This is an additional burden to the physical discomfort it may cause.
THE PSOPROTECT ME SURVEY
For people with psoriasis, the Covid-19 pandemic has likely resulted in shifts in medication and healthcare practices, social behaviours and emotional wellbeing.
COVID-19 AND DERMATOLOGICAL CONDITIONS
Professor Chris Griffiths explains how individuals can reduce the risk of spreading COVID-19 through behavioural and lifestyle modifications.
PSORIASIS AND COVID-19: YOUR MENTAL WELL-BEING
Professor Christine Bundy, shares her top tips on managing anxieties and concerns during the COVID-19 pandemic.
LIVING WITH PSORIASIS
Psoriasis can have a profound impact on a person's quality of life, including their physical and emotional well-being and their activities of daily living.
DEVELOPING CLINICAL DIAGNOSTIC CRITERIA FOR PSORIASIS
Global Psoriasis Atlas PhD Student, Maha Abo-Tabik, is working to develop a diagnostic criteria for psoriasis. Her aim is to develop a clinical examination-based diagnostic tool for chronic plaque psoriasis in adults (age 18 years and above).
PSORIASIS AND CANCER
GPA PhD student, Alex Trafford, completed a systematic review and meta-analysis on the “Association of Psoriasis with the Risk of Developing or Dying of Cancer” now published in, JAMA Dermatology.
HOW TO LEAD A FULL LIFE WITH PSORIASIS
Living with psoriasis can be tough. If you are one of the many millions who has this complex skin condition, you will already know how frustrating and challenging it can be to cope with the symptoms.
WHY YOU SHOULD CONNECT WITH OTHER PEOPLE WHO HAVE PSORIASIS
At least 60 million people in the world have psoriasis. Although there are many questions that remain unanswered about this complex disease, one thing is certain: we are stronger when we connect.
A FIRST FOR PEOPLE WITH PSORIASIS AND EXPERTS
Years of dedicated work has led to the launch of the world’s first Global Psoriasis Atlas.
Global Psoriasis Atlas Quarterly Newsletter – April 2021 – Issue No. 10
Welcome to the tenth edition of the Global Psoriasis Atlas (GPA) newsletter.
Global Psoriasis Atlas Quarterly Newsletter – July2021 – Issue No. 11
Welcome to the eleventh edition of the Global Psoriasis Atlas (GPA) newsletter.